CN114409611A - Oxadiazole hydrazide compound and preparation method and application thereof - Google Patents
Oxadiazole hydrazide compound and preparation method and application thereof Download PDFInfo
- Publication number
- CN114409611A CN114409611A CN202210090460.2A CN202210090460A CN114409611A CN 114409611 A CN114409611 A CN 114409611A CN 202210090460 A CN202210090460 A CN 202210090460A CN 114409611 A CN114409611 A CN 114409611A
- Authority
- CN
- China
- Prior art keywords
- unsubstituted
- optionally substituted
- canker
- oxadiazole
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 240000007594 Oryza sativa Species 0.000 claims abstract description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 13
- 241000500437 Plutella xylostella Species 0.000 claims abstract description 13
- 235000009566 rice Nutrition 0.000 claims abstract description 13
- 241000207199 Citrus Species 0.000 claims abstract description 9
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 9
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 8
- 239000006002 Pepper Substances 0.000 claims abstract description 7
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 7
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 7
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 7
- 235000021307 Triticum Nutrition 0.000 claims abstract description 6
- -1 amino, hydroxyl Chemical group 0.000 claims description 55
- 230000001580 bacterial effect Effects 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 29
- 239000004495 emulsifiable concentrate Substances 0.000 claims description 23
- 239000012453 solvate Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 18
- 125000003118 aryl group Chemical group 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 241000607479 Yersinia pestis Species 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 229910052805 deuterium Inorganic materials 0.000 claims description 14
- 150000002431 hydrogen Chemical class 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 10
- 125000000304 alkynyl group Chemical group 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 238000006467 substitution reaction Methods 0.000 claims description 8
- 240000008067 Cucumis sativus Species 0.000 claims description 7
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 244000052769 pathogen Species 0.000 claims description 7
- 230000001717 pathogenic effect Effects 0.000 claims description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 7
- 240000002791 Brassica napus Species 0.000 claims description 6
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 6
- 241000233622 Phytophthora infestans Species 0.000 claims description 6
- 240000003889 Piper guineense Species 0.000 claims description 6
- 241000221662 Sclerotinia Species 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 241000123650 Botrytis cinerea Species 0.000 claims description 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 5
- 241000223195 Fusarium graminearum Species 0.000 claims description 5
- 208000031888 Mycoses Diseases 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000001831 (C6-C10) heteroaryl group Chemical group 0.000 claims description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 4
- 244000298697 Actinidia deliciosa Species 0.000 claims description 4
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 4
- 208000035143 Bacterial infection Diseases 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 4
- 240000003768 Solanum lycopersicum Species 0.000 claims description 4
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 4
- 235000021014 blueberries Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 235000010485 konjac Nutrition 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000004546 suspension concentrate Substances 0.000 claims description 4
- 239000004562 water dispersible granule Substances 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000003944 tolyl group Chemical group 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 230000002363 herbicidal effect Effects 0.000 claims description 2
- 239000004009 herbicide Substances 0.000 claims description 2
- 239000000252 konjac Substances 0.000 claims description 2
- 230000000391 smoking effect Effects 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 150000004866 oxadiazoles Chemical class 0.000 claims 3
- 125000004799 bromophenyl group Chemical group 0.000 claims 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims 2
- 125000001207 fluorophenyl group Chemical group 0.000 claims 2
- 125000004360 trifluorophenyl group Chemical group 0.000 claims 2
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 13
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 abstract description 12
- 244000052616 bacterial pathogen Species 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 241000209140 Triticum Species 0.000 abstract description 5
- 244000053095 fungal pathogen Species 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 3
- 206010039509 Scab Diseases 0.000 abstract description 3
- 241000238631 Hexapoda Species 0.000 abstract description 2
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 229940079593 drug Drugs 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 230000004071 biological effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 244000000005 bacterial plant pathogen Species 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 239000000575 pesticide Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 230000000749 insecticidal effect Effects 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- 241001272684 Xanthomonas campestris pv. oryzae Species 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 4
- 239000005794 Hymexazol Substances 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 4
- 239000006013 carbendazim Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000003032 phytopathogenic effect Effects 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 150000005072 1,3,4-oxadiazoles Chemical class 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- OIWIYLWZIIJNHU-UHFFFAOYSA-N 1-sulfanylpyrazole Chemical compound SN1C=CC=N1 OIWIYLWZIIJNHU-UHFFFAOYSA-N 0.000 description 2
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical group NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 2
- 125000006280 2-bromobenzyl group Chemical group [H]C1=C([H])C(Br)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006290 2-hydroxybenzyl group Chemical group [H]OC1=C(C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000002927 2-methoxybenzyl group Chemical group [H]C1=C([H])C([H])=C(C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 2
- 125000006494 2-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C([H])=C(C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 2
- 125000006279 3-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Br)=C1[H])C([H])([H])* 0.000 description 2
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 2
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 2
- 125000006291 3-hydroxybenzyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(=C1[H])C([H])([H])* 0.000 description 2
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000006495 3-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 2
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 2
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 2
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- RSNWORHVUOZYLT-UHFFFAOYSA-N 5-[[(2-sulfanylidene-3h-1,3,4-thiadiazol-5-yl)amino]methylamino]-3h-1,3,4-thiadiazole-2-thione Chemical compound S1C(=S)NN=C1NCNC1=NNC(=S)S1 RSNWORHVUOZYLT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000228197 Aspergillus flavus Species 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000500441 Plutellidae Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
- 229960004884 fluconazole Drugs 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 125000006168 tricyclic group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000009333 weeding Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- IAZSXUOKBPGUMV-UHFFFAOYSA-N 1-butyl-3-methyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CCCC[NH+]1CN(C)C=C1 IAZSXUOKBPGUMV-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000004293 19F NMR spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- QWDJAZKQUMSQPQ-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]acetohydrazide Chemical compound NNC(=O)CC1=CC=C(C(F)(F)F)C=C1 QWDJAZKQUMSQPQ-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- HCNVXDPRTRLNFX-UHFFFAOYSA-N 2h-1,3,4-oxadiazine Chemical group C1OC=CN=N1 HCNVXDPRTRLNFX-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- 125000003119 4-methyl-3-pentenyl group Chemical group [H]\C(=C(/C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241001536324 Botryococcus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000520892 Xanthomonas axonopodis Species 0.000 description 1
- 241000589655 Xanthomonas citri Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical group C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004617 chromonyl group Chemical group O1C(=CC(C2=CC=CC=C12)=O)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000006085 pyrrolopyridyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000007280 thionation reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to an oxadiazole hydrazide compound and a preparation method and application thereof. The compound has a structure shown as a general formula (I):
Description
Technical Field
The invention relates to the technical field of medicinal chemistry, in particular to a substituted benzyl, phenoxy (sulfur) methylene and 1, 3, 4-oxadiazole hydrazide compound and a preparation method and application thereof.
Background
Fungal diseases not only seriously affect the yield of crops, but also threaten the health of human beings. Wheat scab, pepper wilt, potato late blight and rape sclerotinia are widely existed in crops such as wheat, pepper, potato and rape in agriculture. Currently, common chemical drugs are hymexazol, carbendazim and the like, but the conventional chemical drugs have the problems of poor control effect, enhanced resistance of pathogenic bacteria after long-term use, environmental pollution and the like, so that the development of novel pesticides with high activity and high selectivity is urgently needed.
Heterocyclic compounds have the characteristics of structural diversity and biological activity diversity, and attract extensive attention in the fields of medicinal chemistry, agrochemical chemistry and organic chemistry. The oxadiazole compound has broad-spectrum medical and pesticide biological activity, the typical structure of the oxadiazole compound is 1, 3, 4-oxadiazole, and the biological activity comprises insect killing, weeding, virus resisting, sterilization, malaria resisting, cancer resisting, inflammation resisting, oxidation resisting, AIDS resisting, tuberculosis resisting, tumor resisting and the like. On the other hand, molecules containing hydrazide (-CO-NH-) skeletons exhibit biological activities such as sterilization, disinsection, and weeding. The 1, 3, 4-oxadiazole structure with wide biological activity is combined with the hydrazide substructure to prepare the 1, 3, 4-oxadiazole hydrazide derivative, and a compound with higher biological activity is expected to be found from the 1, 3, 4-oxadiazole hydrazide derivative, so that an important scientific basis is provided for the research and development of new pesticides.
The research on the biological activity of 1, 3, 4-oxadiazole and hydrazide compounds has progressed as follows:
2017, Wang et al [ Wang, P.Y.; shao, w.b.; xue, h.t.; fang, h.s.; zhou, j.; wu, z.b.; song, b.a.; yang, S.Synthesis of novel 1, 3, 4-oxoderivative as modifying reagents and reagents [ J].Res.Chem.Intermediat.,2017,43,6115-6130.]A series of 1, 3, 4-oxadiazole derivatives are designed and synthesized, and the biological activity of the derivatives is researched. The result shows that the compound 9 has better activity of resisting citrus canker pathogen (Xac)Of which EC505.9 +/-0.1 mu g/mL, which is superior to the control drug of thiediazole copper (EC)50=77.0±2.0μg/mL)。
In 2014, Li et al [ Li, P.; shi, l.; yang, x.; yang, L.; chen, x.w.; wu, f.; shi, q.c.; xu, w.m.; he, m.; hu, d.y.; song, B.A. design, synthesis, and antibacterial activity against bacteria leaf bright and leaf stream of 2, 5-substistuted-1, 3, 4-oxydiazole/thiodiazole leaf derivative [ J].Bioorg.Med.Chem.Lett.,2014,24,1677-1680.]A series of 2, 5-substituted-1, 3, 4 oxadiazole sulfone derivatives were synthesized, and their antibacterial activity against bacterial blight of rice (Xoo) was evaluated. The results show that the compound 13 has good antibacterial activity on rice bacterial blight bacteria, and the EC of the compound50The value is 1.07 +/-0.68 mu g/mL, which is superior to that of the control drug bismerthiazol (EC)50Values of 92.61. + -. 2.15. mu.g/mL) and Thiodiazole copper (EC)50The value was 121.82. + -. 3.59. mu.g/mL).
2015, Shi et al [ Shi, L; li, P.; wang, w.l; gao, m.n.; wu, z.x.; song, x.p.; hu, D.Y.antibacterial activity and mechanism of action of sulfone derivatives stabilizing 1, 3, 4-oxadiazine moieties on edge bacterial leaf bright [ J].Molecules,2015,20,11660-11675.]A series of derivatives containing 1, 3, 4-oxadiazole sulfone are designed and synthesized, and the antibacterial activity of the derivatives is researched. The results show that the compounds all show effective antibacterial activity, EC, on rice bacterial blight (Xoo)50Value-average ratio of bismerthiazol (EC)5092.61 ± 2.15 μ g/mL) and thiediazole copper (EC)50121.82 ± 3.59 μ g/mL) low. Wherein the compound 12 has good activity of resisting rice bacterial blight disease EC50The value was 9.89. + -. 1.52 ug/mL.
2016, Khalilullah et al [ Khalilullah, h.; khan, s.; nomani, m.s.; a series of differently substituted 1, 3, 4-oxadiazole derivatives were synthesized and screened for their antibacterial activity by using Ahmed, B.Synthesis, catalysis and antibacterial activity of benzodioxan ring derivatives [ J ]. Arab.J.chem., 2016, 9, 1029-. The results of the biological activity tests show that the Minimum Inhibitory Concentration (MIC) of the compound 3 on Aspergillus niger (A.niger) is 1 mug/mL, which is better than that of the control drug fluconazole (16 mug/mL). The minimum inhibitory concentration of the compound 4 to aspergillus niger and aspergillus flavus (A.flavu) is 8 mug/mL, and compared with the control drug fluconazole (16 and 8 mug/mL respectively), the antibacterial activity is more obvious.
2019, Wang et al [ Wang, X.B.; fu, x.c.; chen, m.; wang, a.; yan, j.h.; mei, y.d.; wang, m.q.; yang, C.L. novel 1, 3, 5-thiadiazine-2-thionation relating ahydazidie: design, synthesis and biological evaluation against phytopathogenic fusion in vitro and in vivo [ J].Bio.Med.Chen.,2019,10,953-961.]A series of 1, 3, 5-thiadiazine-2-thioketone derivatives containing hydrazine groups are designed and synthesized, and biological activity of the derivatives is tested. The results show that the synthesized compound 16 has EC for in vitro activity test on rice sheath blight50The value is 0.24 mu g/mL, and is 2 times more effective than a commercial bactericide carbendazim (0.55 mu g/mL), the in vivo effect of the compound 16 on resisting rice sheath blight bacteria is further evaluated, and the prevention and control effects of the rice leaves are 98.58% and 61.27% respectively under the control of 200mg/mL and 100 mg/mL.
Disclosure of Invention
The invention provides a substituted benzyl, phenoxy (sulfur) methylene, 1, 3, 4-oxadiazole hydrazide compound or a salt or solvate thereof.
Another object of the present invention is to provide an intermediate compound for preparing the above compound or a salt thereof or a solvate thereof, and a preparation method thereof.
It is a further object of the present invention to provide a composition comprising the above compound or a salt or solvate thereof.
It is also an object of the present invention to provide the above compound or a salt thereof or a solvate thereof, or use of the composition.
Another object of the present invention is to provide a method for controlling agricultural pests using the above compound or a salt thereof or a solvate thereof, or the composition.
In order to realize the purpose, the invention adopts the following technical scheme:
a substituted benzyl, phenoxy (thio) methylene, 1, 3, 4-oxadiazole hydrazide compound or a salt or solvate thereof, which has the structure shown in the general formula (I):
wherein
R is selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, and optionally substituted or unsubstituted heteroaryl;
R1one or more selected from the group consisting of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, and optionally substituted or unsubstituted heteroaryl;
preferably, R is selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl; preferably, R is selected from one or more of hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl and substituted or unsubstituted C6-C10 heteroaryl, wherein the substituted refers to substitution by one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxyl, halogen, nitro and trifluoromethyl; more preferably, R is selected from hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, wherein said substitution refers to substitution with one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxy, halogen, nitro, trifluoromethyl; most preferably, R is selected from the group consisting of hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, phenyl, benzyl, 2-methoxybenzyl, 3-methoxybenzyl, 4-methoxybenzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxybenzyl, 3-hydroxybenzyl, 4-hydroxybenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-trifluoromethylbenzyl, 3-trifluoromethylbenzyl, 4-trifluoromethylbenzyl, 2-chlorophenyl, 2, 4-dichlorophenyl, 4-chlorophenyl, 4-methylphenyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, phenylthio, 2, 4-dichlorophenoxy, 4-fluorophenoxy, 4-methoxyphenoxy.
Preferably, R1One or more selected from the group consisting of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, and optionally substituted or unsubstituted heteroaryl; preferably, R1One or more selected from hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl and substituted or unsubstituted C6-C10 heteroaryl, wherein the substituted refers to substitution by one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxyl, halogen, nitro and trifluoromethyl; more preferably, R1Selected from the group consisting of hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, substituted or unsubstituted phenylOr unsubstituted benzyl, wherein substituted refers to substitution with one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxy, halogen, nitro, trifluoromethyl; most preferably, R1Selected from the group consisting of hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, propenyl, allyl, methoxy, ethoxy, propoxy, butoxy, phenyl, benzyl, 2-methoxybenzyl, 3-methoxybenzyl, 4-methoxybenzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxybenzyl, 3-hydroxybenzyl, 4-hydroxybenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-trifluoromethylbenzyl, 3-trifluoromethylbenzyl, 4-trifluoromethylbenzyl, 2-fluorophenyl, 3-fluorophenyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, 4-methylphenyl, 4-chlorophenyl, 4-bromophenyl.
Most preferably, the compound or salt or solvate thereof is selected from the following specific compounds:
the invention also provides an intermediate compound for preparing the substituted benzyl, phenoxy (sulfur) methylene and 1, 3, 4-oxadiazole hydrazide compound or salt or solvate thereof, which is characterized by comprising the following components in percentage by weight:
the invention also provides a preparation method of the substituted benzyl, phenoxy (sulfur) methylene, 1, 3, 4-oxadiazole hydrazide compound or salt or solvate thereof, which is characterized by comprising the following steps:
r, R therein1As described above.
The invention also provides a composition containing the compound or the salt or the solvate thereof, and an agriculturally acceptable auxiliary agent or bactericide, pesticide or herbicide; preferably, the formulation of the composition is selected from Emulsifiable Concentrates (EC), Dusts (DP), Wettable Powders (WP), Granules (GR), Aqueous Solutions (AS), Suspension Concentrates (SC), ultra low volume sprays (ULV), Soluble Powders (SP), Microcapsules (MC), smoking agents (FU), aqueous Emulsions (EW), water dispersible granules (WG).
The compound or the salt or the solvate thereof, or the composition can be used for controlling agricultural pests, preferably bacterial or fungal diseases of plants; more preferably, the agricultural pests are plant leaf blight and plant canker; most preferably, the agricultural pests are rice bacterial leaf blight, cucumber bacterial leaf blight, konjac bacterial leaf blight, citrus canker, grape canker, tomato canker, kiwi canker, apple canker, cucumber botrytis cinerea, pepper fusarium wilt pathogenic bacteria, sclerotinia rot pathogenic bacteria of colza, wheat scab pathogenic bacteria, potato late blight pathogenic bacteria, blueberry root rot pathogenic bacteria and diamond back moth.
The invention also provides a method for controlling agricultural pests, which comprises the step of enabling the compound or the salt or the solvate thereof or the composition to act on pests or living environments thereof; preferably, the agricultural pest is a bacterial or fungal disease of a plant; more preferably, the agricultural pests and diseases are rice bacterial leaf blight, tobacco bacterial wilt, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, grape canker, tomato canker, kiwi canker, apple canker, cucumber botrytis cinerea, pepper fusarium wilt pathogen, sclerotinia rot of colza, wheat fusarium graminearum, potato late blight, blueberry root rot pathogen and plutella xylostella.
The invention also provides a method for protecting a plant from an agricultural pest comprising the method step wherein the plant is contacted with the compound or salt or solvate thereof, or the composition.
The term "alkyl" as used herein is intended to include both branched and straight chain saturated hydrocarbon radicals having the specified number of carbon atoms. E.g. "C1-10Alkyl "(or alkylene) groups are intended to be C1, C2, C3, C4, C5, C6, C7, C8, C9 and C10 alkyl groups. In addition, for example "C1-6Alkyl "denotes an alkyl group having 1 to 6 carbon atoms. Alkyl groups may be unsubstituted or substituted such that one or more of its hydrogen atoms are replaced with another chemical group. Examples of alkyl groups include, but are not limited to, methyl (Me), ethyl (Et), propyl (e.g., n-propyl and isopropyl), butyl (e.g., n-butyl, isobutyl, t-butyl), pentyl (e.g., n-pentyl, isopentyl, neopentyl), and the like.
"alkenyl" is a hydrocarbon group that includes both straight and branched chain structures and has one or more carbon-carbon double bonds that occur at any stable point in the chain. E.g. "C2-6Alkenyl "(or alkenylene) is intended to include C2, C3, C4, C5, and C6 alkenyl. Examples of alkenyl groups include, but are not limited to, ethenyl, 1-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-methyl-2-propenyl, 4-methyl-3-pentenyl, and the like.
"alkynyl" is intended to include both straight and branched chain hydrocarbons having one or more carbon-carbon triple bonds at any stable point in the chain. E.g. "C2-6Alkynyl "(or alkynylene) is intended to include C2, C3, C4, C5, and C6 alkynyl; such as ethynyl, propynyl, butynyl, pentynyl, hexynyl and the like.
The term "substituted" as used herein means that any one or more hydrogen atoms on the designated atom or group is replaced with the designated group of choice, provided that the general valence of the designated atom is not exceeded. If not otherwise stated, substituents are named to the central structure. For example, it is understood that when (cycloalkyl) alkyl is a possible substituent, the point of attachment of the substituent to the central structure is in the alkyl moiety. As used herein, a cyclic double bond is a double bond formed between two adjacent ring atoms (e.g., C ═ C, C ═ N or N ═ N). When referring to substitution, especially polysubstitution, it is meant that the various substituents are substituted at various positions on the indicated group, e.g. dichlorophenyl means 1, 2-dichlorophenyl, 1, 3-dichlorophenyl and 1, 4-dichlorophenyl.
Combinations of substituents and or variables are permissible only if such combinations result in stable compounds or useful synthetic intermediates. A stable compound or stable structure implies that the compound is sufficiently stable to be isolated in useful purity from the reaction mixture and subsequently formulated to form an effective therapeutic agent. Preferably, the compounds described so far do not contain N-halogen, S (O)2H or S (O) H group.
The term "aryl" refers to monocyclic or bicyclic aromatic hydrocarbon groups having 6 to 12 carbon atoms in the ring portion, such as phenyl and naphthyl, each of which may be substituted.
The term "halogen" or "halogen atom" refers to chlorine, bromine, fluorine and iodine.
The term "haloalkyl" refers to a substituted alkyl having one or more halo substituents. For example, "haloalkyl" includes mono-, di-and trifluoromethyl; even if the halo in a haloalkyl group is specified as fluoro, chloro, bromo, iodo, the same refers to a substituted alkyl group having one or more fluoro, chloro, bromo, iodo substituents.
The term "heteroaryl" refers to substituted and unsubstituted aromatic 5 or 6 membered monocyclic groups, 9-or 10-membered bicyclic groups, and 11 to 14 membered tricyclic groups having at least one heteroatom (O, S or N) in at least one ring, said heteroatom containing ring preferably having 1, 2 or 3 heteroatoms selected from O, S and N. The heteroatom-containing heteroaryl groups can contain one or two oxygen or sulfur atoms per ring and/or from 1 to 4 nitrogen atoms, provided that the total number of heteroatoms in each ring is 4 or less and each ring has at least one carbon atom. The fused rings completing the bicyclic and tricyclic groups may contain only carbon atoms and may be saturated, partially saturated, or unsaturated. The nitrogen and sulfur atoms may optionally be oxidized and the nitrogen atoms may optionally be quaternized. Bicyclic or tricyclic heteroaryl groups must include at least one fully aromatic ring, and the other fused rings may be aromatic or non-aromatic. The heteroaryl group may be attached at any available nitrogen or carbon atom of any ring. If the other ring is cycloalkyl or heterocyclic, it is additionally optionally substituted with ═ O (oxygen), as valency permits.
Exemplary monocyclic heteroaryls include pyrrolyl, pyrazolyl, pyrazolinyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, furanyl, thienyl, oxadiazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, and the like.
Exemplary bicyclic heteroaryls include indolyl, benzothiazolyl, benzodioxolyl, benzoxazolyl, benzothienyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, benzofuranyl, indolizinyl, benzofuranyl, chromonyl, coumarinyl, benzofuranyl, cinnolinyl, quinoxalinyl, indazolyl, pyrrolopyridyl, fluoropyridinyl, dihydroisoindolyl, tetrahydroquinolinyl, and the like.
The compounds of the invention are understood to include both the free form and salts thereof, unless otherwise indicated. The term "salt" means an acid and/or base salt formed from an inorganic and/or organic acid and a base. In addition, the term "salt" may include zwitterions (internal salts), such as when the compound of formula I contains a basic moiety, such as an amine or pyridine or imidazole ring, and an acidic moiety, such as a carboxylic acid. Pharmaceutically acceptable (i.e., non-toxic, physiologically acceptable) salts are preferred, such as acceptable metal and amine salts, wherein the cation does not contribute significantly to the toxicity or biological activity of the salt. However, other salts may be useful, such as separation or purification steps in the preparation process, and are therefore included within the scope of the present invention.
Preferably, C1-C10Alkyl refers to methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and isomers thereof; c1-C10Alkoxy refers to methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy and isomers thereof; c2-C5Alkenyl means BAlkenyl, propenyl, allyl, butenyl, pentenyl and isomers thereof.
When reference is made to substituents being alkenyl, alkynyl, alkyl, halo, aryl, heteroaryl, alkoxy, cycloalkyl, hydroxy, amino, mercapto, phosphino, or when these substituents are specifically alkenyl, alkynyl, alkyl, halo, aryl, heteroaryl, alkoxy, cycloalkyl, hydroxy, amino, mercapto, phosphino as specified, one to three of the above substituents are meant. Such as methylphenyl refers to phenyl substituted with one to three methyl groups.
By adopting the technical scheme, a series of substituted benzyl, phenoxy (thio) methylene and 1, 3, 4-oxadiazole hydrazide compounds are synthesized on the basis of 1, 3, 4-oxadiazole and hydrazide fragments, and the compounds are found to have good inhibition effect on pathogenic fungi, have good inhibition effect on pathogenic fungi [ such as Gibberella zeae (G.z.), Sclerotinia sclerotiorum (S.s), and the like ], and provide important scientific basis for research, development and creation of new pesticides.
Examples
The invention is further illustrated by the following examples. It should be understood that the method described in the examples is only for illustrating the present invention and not for limiting the present invention, and that simple modifications of the preparation method of the present invention based on the concept of the present invention are within the scope of the claimed invention. All the starting materials and solvents used in the examples are commercially available products.
Example 1: preparation of intermediate 5- (4-trifluoromethylbenzyl) -1, 3, 4-oxadiazole-2-carboxylic acid methyl ester
3.84g of 4-trifluoromethylphenylacethydrazide (17.60mmol) was placed in a 150mL round-bottom flask, and 25.0mL of OCL was added3Then adding 2.43mL (26.39mmol) of the mixture, and heating to 75 ℃ for reaction; 5hTLC to monitor the reaction progress, the reaction is complete, and the POCl is removed partially by distillation and desolventization under reduced pressure3200mL of EA-dissolved system, washing with 100mL of water for 3 times, drying the organic phase with anhydrous sodium sulfate, suction-filtering, vacuum-distilling for desolventizing, and subjecting to column chromatography (PE/EA: 10/1) to obtain intermediate, which is 1.72g of pale yellow solid with high yieldIt was 34.2%. The nuclear magnetic data are:1H NMR(400MHz,DMSO)δ7.75(d,J=8.1Hz,2H,Ph-H),7.60(d,J=8.0Hz,2H,Ph-H),4.54(s,2H,-CH2-),3.93(s,3H,-CH3-).13C NMR(101MHz,DMSO)δ167.42,157.37,154.91,139.15,130.51,128.52(dd,2JC-F=57.2,38.4Hz),126.13(dd,3JC-F=9.3,5.6Hz),124.66(dd,1JC-F=543.9,271.5Hz),53.97,30.92.19F NMR(376MHz,DMSO)δ-61.01.
example 2: preparation of 5- (4-trifluoromethylbenzyl) -N' -phenyl-1, 3, 4-oxadiazole-2-carbohydrazide
Adding 0.3g (1.05mmol) of 5- (4-trifluoromethylbenzyl) -1, 3, 4-oxadiazole-2-carboxylic acid methyl ester into a 15mL pressure-resistant bottle, adding 0.23g (2.1mmol) of phenylhydrazine and 2g of (1-butyl-3-methylimidazole) chloride, introducing argon, heating to 100 ℃ for reaction for about 2 hours, monitoring the reaction process by TLC, and stopping the reaction after the reaction is finished; 150mL of EA dissolves a compound in the system, 50mL of EA washes for 3 times, the organic phase is added with anhydrous sodium sulfate for drying, suction filtration and decompression distillation for desolventizing to obtain a light yellow solid, the anhydrous ethanol is added for recrystallization to separate out the light yellow solid, the suction filtration and a small amount of anhydrous ethanol washing are carried out, the compound is placed under an infrared lamp for drying, and then 0.19g is weighed, and the yield is 47.7%.
Other target compounds were synthesized by following the procedures of the above examples using the corresponding starting materials or substituents.
The structures, nuclear magnetic resonance hydrogen spectra and carbon spectra data of the synthesized substituted benzyl, phenoxy (sulfur) methylene and 1, 3, 4-oxadiazole hydrazide partial compounds are shown in table 1, and the physicochemical properties are shown in table 2.
TABLE 1 NMR Hydrogen and carbon spectra data for compounds of the present application
Table 2 physicochemical properties of the compounds of the present application
Pharmacological example 1:
EC50(mean effective concentration) is an important index for evaluating the sensitivity of plant pathogenic bacteria to compounds, and is also an important parameter for setting the concentration of compounds when researching the action mechanism of target compounds. In the concentration gradient experiment, proper 5 concentrations are set by a double dilution method, finally the inhibition rate of the medicament on plant pathogenic bacteria and the medicament concentration are converted into paired numerical values, a toxicity curve is obtained through SPSS software regression analysis, and EC is calculated50。
Testing the effective medium concentration EC of target compound on plant pathogenic bacteria by adopting a growth rate method50The test subjects were gibberella zeae (G.z), botryococcus (b.d), sclerotinia sclerotiorum (S.s), colza anthracnose (C.h), capsicum wilt (F.o), and potato late blight (P.i). DMSO was dissolved in the medium as a blank control. Weighing a compound to be detected by a ten-thousandth balance, adding 1mLDMSO to dissolve the compound, transferring the compound to a 15mL sterilized centrifuge tube in a sterile operating platform, adding 9mL of water (Tween-20) for constant volume to 10mL, pouring the water into a melted culture medium, uniformly mixing, and then uniformly subpackaging the mixture into 9 culture dishes for cooling for later use; in an aseptic operation table, a puncher (5mm) is burnt and sterilized, bacterial colonies are made into bacterial cakes, the bacterial cakes are connected to a middle clamp of a culture medium by a bacterial ring, the bacterial cakes are cultured for about 5 days at the temperature of 25-28 ℃, when the bacterial colonies of a blank control grow to about 6cm, the bacterial colonies are measured for 2 times by a ruler according to a cross method, and the average value is taken as the diameter of the bacterial colonies. The hypha growth inhibition rate of each concentration is calculated according to a calculation formula, and a linear regression equation is made according to the concentration and the corresponding inhibition rate, so that EC is obtained50Values, hymexazol, carbendazim were tested together as a drug control.
Inhibition ratio (%) - (N1-N2)/(N1-0.5) × 100
0.5-diameter of mother fungus cake.
N1 — control colony diameter, i.e. colony diameter of control group;
n2 — diameter of treated colonies, i.e. colonies treated with the compound of interest;
the examples of the present invention are given to illustrate the technical solution of the present invention, but the contents of the examples are not limited thereto, and the experimental results of the target compounds are shown in table 3.
TABLE 3 EC of the Compounds of the present application against phytopathogenic fungi50
As can be seen from Table 3, the compound of interest showed good inhibitory activity against phytopathogenic fungi in vitro. Wherein 18 the compound has anti-Gibberella tritici EC50Lower than the control drug carbendazim (EC)500.95 μ g/mL). 4, 15, 16 anti-Proteus Vitis-vinifera EC in these 3 compounds50The value is lower than 1 mu g/mL, the activity of most compounds is superior to that of hymexazol, and the hymexazol can be used for preparing pesticides for resisting plant pathogenic fungi.
Pharmacological example 2:
EC50(mean effective concentration) is an important index for evaluating the sensitivity of plant pathogenic bacteria to compounds, and is also an important parameter for setting the concentration of compounds when researching the action mechanism of target compounds. In the concentration gradient experiment, proper 5 concentrations are set by a double dilution method, finally the inhibition rate of the medicament on plant pathogenic bacteria and the medicament concentration are converted into paired numerical values, a toxicity curve is obtained through SPSS software regression analysis, and EC is calculated50。
Testing the effective medium concentration EC of target compound on plant pathogenic bacteria by adopting turbidity method50The test subjects were rice bacterial blight (Xoo) and citrus canker (Xac). DMSO was dissolved in the medium as a blank control. The bacterial blight of rice (bacterial blight of rice)The strain is in M210 solid culture medium) is put into NB culture medium, and is shake-cultured in a constant temperature shaking table at 28 ℃ and 180rpm to logarithmic phase for standby; the citrus canker pathogen (on M210 solid medium) was placed in NB medium and shake-cultured in a constant temperature shaker at 28 ℃ and 180rpm until logarithmic phase for use. 5mL of toxic NB-containing liquid medium prepared by the drug (compound) into different concentrations (e.g., 100, 50, 25, 12.5, 6.25. mu.g/mL) was added into a test tube, 40. mu.L of NB liquid medium containing plant-pathogenic bacteria was added, and shaking was carried out in a constant temperature shaker at 28-30 ℃ and 180rpm, wherein the bacterial blight of rice was cultured for 36h and the bacterial canker of citrus was cultured for 48 h. The OD was measured on a spectrophotometer using the bacterial solutions of the respective concentrations595Value, and additionally determining the OD of the corresponding concentration of the sterilized NB-containing liquid medium595The value is obtained.
Corrected OD value-bacteria-containing medium OD value-sterile medium OD value
Percent inhibition is [ (OD value of control medium liquid OD value after correction-OD value of medium containing toxin corrected)/OD value of control medium liquid OD value after correction ] × 100
The examples of the present invention are given to illustrate the technical solutions of the present invention, but the contents of the examples are not limited thereto, and the experimental results of the target compounds are shown in table 4.
TABLE 4 EC of the Compounds of the present application against phytopathogenic bacteria50
As can be seen from Table 4, the target compounds showed good inhibitory activity against plant pathogenic bacteria such as rice bacterial blight and citrus canker in the in vitro test. Compounds 8 and 9 showed good inhibitory activity against Xanthomonas oryzae pv. oryzae, Xoo, with EC thereof5011.4-17.7 mug/mL; compounds 9, 11 and 15 against Leptospira citrea (Xanthomonas axonopodis)Cv. citi, Xac) showed excellent inhibitory activity, EC thereof503.79-7.98 mu g/mL; can be used for preparing pesticide for resisting plant pathogenic bacteria.
Pharmacological example 3:
and carrying out a cabbage moth poisoning activity test on the designed synthetic target compound by adopting a leaf soaking feeding method. Firstly, fresh cabbage leaves which are cultivated and available are picked, cleaned by clear water and dried for standby. Preparing a culture dish, cutting circular filter paper with the same size as the inner diameter of the culture dish, putting the circular filter paper into the bottom of the culture dish for standby, and sucking new prepared secondary water by using a disposable rubber head dropper to wet the filter paper placed at the bottom of the culture dish for standby. Then dispensing medicines, calculating and weighing, preparing 500 mu g/mL and 200 mu g/mL liquid medicine to be detected (40 mu L DMSO is added after the medicine to be detected is weighed, then 1% Tween-80 aqueous solution prepared by secondary water is diluted to a required concentration), cutting cabbage leaves prepared in advance into small pieces with basically consistent sizes and shapes, putting the small pieces into the liquid medicine to be detected, soaking the small pieces into the liquid medicine to be detected for about ten seconds, taking the small pieces out of a culture dish, taking the three medicines in parallel, taking Tween water as a blank control, picking 10 diamondback moth larvae with the same size in each parallel, covering the culture dish, putting the culture dish into an artificial intelligent climate box (temperature: 28 ℃, humidity 80%), appropriately supplementing water in the culture dish every day, taking the culture dish out after 72 hours, counting the death number of the diamondback moths, recording data, and calculating the inhibition rate. The insecticidal activity calculation formula is as follows:
the inhibition rate is (drug-containing death rate-drug-free death rate)/the total number of diamondback moths put in the solution is multiplied by 100 percent
The examples of the present invention are given to illustrate the technical means of the present invention, but the contents of the examples are not limited thereto, and the experimental results of the target compounds are shown in table 5.
TABLE 5 Activity results of the compounds of the present application against Plutella xylostella
As can be seen from table 5, at 500 μ g/mL, the insecticidal activity against plutella xylostella of compound 11 was 85.2% close to that of the control drug tebufenozide, and the insecticidal activities against plutella xylostella of compounds 31 and 32 were 74.1% and 63.0%, respectively, except that the insecticidal activities against plutella xylostella of the remaining compounds were much lower than that of the control drug. At 200 mu g/mL, the insecticidal activity of all target compounds on the diamondback moth is lower than that of a control medicament, and part of the compounds have no toxic or killing effect on the diamondback moth. The compounds have the potential to become insecticidal pesticides.
Claims (9)
1. An oxadiazole hydrazide compound or a stereoisomer thereof, or a salt or a solvate thereof, which is characterized in that: it has a structure shown in general formula (I):
wherein
R is selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, and optionally substituted or unsubstituted heteroaryl;
R1one or more selected from the group consisting of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, and optionally substituted or unsubstituted heteroaryl.
2. A class of oxadiazole hydrazide compounds or a stereoisomer thereof, or a salt or solvate thereof according to claim 1, wherein:
r is selected from one or more of hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl and substituted or unsubstituted C6-C10 heteroaryl, wherein the substituted refers to substitution by one or more of C1-C6 alkyl, C1-C6 alkoxy, S, O, amino, hydroxyl, halogen, nitro and trifluoromethyl;
R1one or more selected from hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl, and substituted or unsubstituted C6-C10 heteroaryl, wherein the substituted refers to substitution by one or more selected from C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxyl, halogen, nitro and trifluoromethyl;
preferably, R is selected from phenyl, chlorophenyl, fluorophenyl, bromophenyl, phenylthio, o-methoxyphenoxy, m-methoxyphenoxy, p-methoxyphenoxy, o-fluorophenoxy, m-fluorophenoxy, p-fluorophenoxy, o-chlorophenoxy, m-chlorophenoxy, p-chlorophenoxy, o-bromophenoxy, m-bromophenoxy, p-bromophenoxy, 2, 3-dichlorophenoxy, 2, 4-dichlorophenoxy, 2, 5-dichlorophenoxy, 2, 6-dichlorophenoxy, 3, 4-dichlorophenoxy, 3, 5-dichlorophenoxy, 1, 2-dichlorophenyl, 1, 3-dichlorophenyl, 1, 4-dichlorophenyl, tolyl, ethylphenyl, propylphenyl, methoxyphenyl, ethoxyphenyl, trifluorophenyl;
R1is selected from phenyl, chlorophenyl, fluorophenyl, bromophenyl, trifluorophenyl, methoxyphenyl, ethoxyphenyl, tolyl, ethylphenyl, propylphenyl.
6. A composition characterized by: a composition comprising a compound according to any one of claims 1 to 3 or a stereoisomer thereof, or a salt or solvate thereof, and an agriculturally acceptable adjuvant or fungicide, insecticide or herbicide; preferably, the formulation of the composition is selected from Emulsifiable Concentrates (EC), Dusts (DP), Wettable Powders (WP), Granules (GR), Aqueous Solutions (AS), Suspension Concentrates (SC), ultra low volume sprays (ULV), Soluble Powders (SP), Microcapsules (MC), smoking agents (FU), aqueous Emulsions (EW), water dispersible granules (WG).
7. Use of a compound according to any one of claims 1 to 3 or a stereoisomer thereof, or a salt or solvate thereof, or a composition according to claim 7, for controlling an agricultural pest, preferably a bacterial or fungal disease of a plant; more preferably, the agricultural pests are plant leaf blight and plant canker; most preferably, the agricultural pests are rice bacterial leaf blight, cucumber bacterial leaf blight, sclerotinia rot of colza, konjac bacterial leaf blight, citrus canker, grape canker, tomato canker, rape anthracnose, kiwi canker, apple canker, botrytis cinerea, pepper fusarium wilt pathogen, sclerotinia rot of colza, fusarium graminearum, potato late blight, blueberry root rot, botrytis cinerea and diamond back moth.
8. A method for controlling agricultural pests is characterized in that: allowing the compound according to any one of claims 1 to 3 or a salt thereof or a solvate thereof, or the composition according to claim 6 to act on harmful substances or their living environments; preferably, the agricultural pest is a bacterial or fungal disease of a plant; more preferably, the agricultural pests and diseases are rice bacterial leaf blight, tobacco bacterial wilt, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, grape canker, tomato canker, kiwi canker, apple canker, cucumber botrytis cinerea, pepper fusarium wilt pathogen, sclerotinia rot of colza, wheat fusarium graminearum, potato late blight, blueberry root rot pathogen and plutella xylostella.
9. A method for protecting a plant from an agricultural pest, characterized by: a method step comprising contacting a plant with a compound of any one of claims 1-3, or a salt or solvate thereof, or a composition of claim 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090460.2A CN114409611A (en) | 2022-01-25 | 2022-01-25 | Oxadiazole hydrazide compound and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090460.2A CN114409611A (en) | 2022-01-25 | 2022-01-25 | Oxadiazole hydrazide compound and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114409611A true CN114409611A (en) | 2022-04-29 |
Family
ID=81277308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210090460.2A Pending CN114409611A (en) | 2022-01-25 | 2022-01-25 | Oxadiazole hydrazide compound and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114409611A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109651350A (en) * | 2019-01-11 | 2019-04-19 | 贵州大学 | The 1,3,4- that heterocycle replaces dislikes (thiophene) diazoles compound and its preparation method and application |
CN111548320A (en) * | 2019-10-09 | 2020-08-18 | 贵州大学 | 1, 3, 4-oxadiazole hydrazide compounds and preparation method and application thereof |
CN112608307A (en) * | 2021-01-29 | 2021-04-06 | 贵州大学 | Heterocyclic ring substituted 1,3, 4-oxadiazole hydrazide compounds, and preparation method and application thereof |
-
2022
- 2022-01-25 CN CN202210090460.2A patent/CN114409611A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109651350A (en) * | 2019-01-11 | 2019-04-19 | 贵州大学 | The 1,3,4- that heterocycle replaces dislikes (thiophene) diazoles compound and its preparation method and application |
CN111548320A (en) * | 2019-10-09 | 2020-08-18 | 贵州大学 | 1, 3, 4-oxadiazole hydrazide compounds and preparation method and application thereof |
CN112608307A (en) * | 2021-01-29 | 2021-04-06 | 贵州大学 | Heterocyclic ring substituted 1,3, 4-oxadiazole hydrazide compounds, and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
ACS: "STN 检索报告", 《STN REGISTRY》, pages 1 - 3 * |
朱建军: "含取代苄基、苯氧(硫)亚甲基的1,3,4-噁二唑(或噻唑)酰肼衍生物的设计合成及生物活性研究", 《中国学位论文全文数据库》, pages 25 - 27 * |
柯少勇;孙婷婷;梁英;杨自文;: "具有生物活性的酰肼衍生物的研究进展", 有机化学, no. 12 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109651350B (en) | Heterocyclic substituted 1,3,4-oxa (thia) diazoles compound and preparation method and application thereof | |
KR20160075565A (en) | Processes for the preparation of pesticidal compounds | |
CN110713512B (en) | Isopropanolamine substructure-containing glycyrrhetinic acid piperazine compounds and preparation method and application thereof | |
CN111454260B (en) | 1,2,3,4-tetrahydro-beta-carboline compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN112608307B (en) | Heterocyclic substituted 1,3,4-oxadiazole hydrazide compound as well as preparation method and application thereof | |
CN111548320A (en) | 1, 3, 4-oxadiazole hydrazide compounds and preparation method and application thereof | |
JPH03118369A (en) | N-phenyl pirazole derivative as insecticide | |
CN113636984B (en) | Morpholine group-containing 1,3, 4-oxadiazole compound and preparation method and application thereof | |
CN113461634B (en) | Thiazole hydrazide compound and preparation method and application thereof | |
CN109942567B (en) | 1,3,4-oxa (thia) diazolyl imidazole compound and preparation method and application thereof | |
CN112624931A (en) | Pterostilbene amine compounds containing isopropanol aromatic ether structure and preparation method and application thereof | |
CN111285814B (en) | Quinazolinone compound containing hydrazone structural unit or stereoisomer thereof, or salt or solvate thereof | |
CN110776548B (en) | Acetoxy ursolic acid piperazine compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
JP6497808B2 (en) | 1,4-Benzothiazine-1,3-dione or -1,1,3-trione derivative and fungicide containing the same as an active ingredient | |
CN114751885B (en) | Coumarin compound containing isopropanolamine structure and preparation method and application thereof | |
CN115260046A (en) | Abietate compound and preparation method and application thereof | |
CN114409611A (en) | Oxadiazole hydrazide compound and preparation method and application thereof | |
CN113549053B (en) | Pyrazoloquine (azolyl) ether compound and application thereof | |
CN112592321A (en) | 1, 2, 3-triazole hydrazide or amide compounds and preparation method and application thereof | |
CN110759911B (en) | Carboline derivative, preparation method thereof and application thereof in preventing and treating plant viruses, killing bacteria and killing insects | |
CN111393359A (en) | Pyridine salt-containing N- (cinnamoyl) -N' - (substituted) propyl hydrazide compound and preparation method and application thereof | |
CN115536543B (en) | Triclosan compound containing isopropanolamine structure and preparation method and application thereof | |
CN110078721B (en) | Triazine-containing pentadiene ketone compound and preparation method and application thereof | |
CN116730954A (en) | Isopropanolamine compound containing chalcone structure, and preparation method and application thereof | |
CN113999222B (en) | Adamantyl oxadiazole-containing compound and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220429 |
|
WD01 | Invention patent application deemed withdrawn after publication |